|Other Names||Poliovirus receptor, Nectin-like protein 5, NECL-5, CD155, PVR, PVS|
|Target/Specificity||The synthetic peptide sequence is selected from aa 329-342 of HUMAN PVR|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors: CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. This may trigger adhesion and secretion of lytic granules and IFN-gamma and activate cytoxicity of activated NK cells. May also promote NK cell-target cell modular exchange, and PVR transfer to the NK cell. This transfer is more important in some tumor cells expressing a lot of PVR, and may trigger fratricide NK cell activation, providing tumors with a mechanism of immunoevasion. Plays a role in mediating tumor cell invasion and migration.|
|Cellular Location||Isoform Alpha: Cell membrane; Single-pass type I membrane protein Isoform Beta: Secreted.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The protein encoded by this gene is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. The external domain mediates cell attachment to the extracellular matrix molecule vitronectin, while its intracellular domain interacts with the dynein light chain Tctex-1/DYNLT1. The gene is specific to the primate lineage, and serves as a cellular receptor for poliovirus in the first step of poliovirus replication. Multiple transcript variants encoding different isoforms have been found for this gene.
Nakai, R., et al. Cancer Sci. 101(5):1326-1330(2010)
Jugessur, A., et al. PLoS ONE 5 (7), E11493 (2010) :
Stanietsky, N., et al. Proc. Natl. Acad. Sci. U.S.A. 106(42):17858-17863(2009)
Carlsten, M., et al. J. Immunol. 183(8):4921-4930(2009)
Kindberg, E., et al. J. Med. Virol. 81(5):933-936(2009)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.